The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

MPN Advances Day 2019 | MPNs: looking to ASH 2019

Name: MPNs: looking to ASH 2019
Uploaded: 2019-11-15T00:00:00.000Z
Duration: 4 min 33 s
Description: Claire Harrison, MD, FRCP, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, shares what myeloproliferative neoplasms (MPNs) updates she is looking forward to hearing about at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition. This interview took place at the MPN Advances Day 2019 in London, UK.

Claire Harrison • 15 Nov 2019

MPN Advances Day 2019

Myeloproliferative Neoplasms Luspatercept Navitoclax Pelabresib

Claire Harrison, MD, FRCP, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, shares what myeloproliferative neoplasms (MPNs) updates she is looking forward to hearing about at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition. This interview took place at the MPN Advances Day 2019 in London, UK.